ARTICLE

FindCenter AddIcon

Johns Hopkins Scientists Give Psychedelics the Serious Treatment

By Tanya Lewis — 2020

Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look.

Read on www.scientificamerican.com

FindCenter Post-Image

My Adventures with the Trip Doctors

My first psilocybin journey began around an altar in the middle of a second-story loft in a suburb of a small city on the Eastern Seaboard.

Article
Michael Pollan
2018
FindCenter AddIcon
FindCenter Post-Image

Not So Fast on Magic Mushrooms

Only a few days ago, millions of Americans probably had never heard of psilocybin, the active agent in psychedelic mushrooms, but thanks to Denver, it is about to get its moment in the political sun.

Article
Michael Pollan
2019
FindCenter AddIcon
FindCenter Post-Image

Roland Griffiths: 5 Fast Facts You Need to Know

Roland Griffiths is a Johns Hopkins University professor, researcher and expert in the field of pharmacology. He is best known for his research into the beneficial effects psilocybin on cancer patients.

Article
Alyssa Choiniere
2019
FindCenter AddIcon
FindCenter Post-Image

The Future of Psychedelic Medicine

This is an exciting time to be involved in psychedelic research. Medical researchers are rediscovering the possible benefits of responsible use of psychedelics in therapeutic settings.

Article
Amanda Feilding
2017
FindCenter AddIcon
FindCenter Post-Image

Interview with Albert Hofmann, the Man Who First Synthesized LSD

The late chemist Albert Hofmann discussed his psychedelic research on LSD in the July, 1976 issue of High Times.

Article
High Times
2020
FindCenter AddIcon

EXPLORE TOPIC

Psychedelic Research